|
0
Votes
vote
First patient to receive the commercial AbioCor Total Replacement Heart could not surviveAbiomed, Inc. (NASDAQ: ABMD), has been informed by Mark Anderson, M.D., associate professor of surgery at UMDNJ-Robert Wood Johnson Medical School and chief of the section of cardiac surgery at both the medical school and Robert Wood Johnson University Hospital, that the first patient to receive ... |

